About this trial
The goal of this clinical trial is to learn if a treatment designed to deal with anger and aggression from a past betrayal will work. The study will be done on active duty military service members and veterans aged 18 or older. The main questions it aims to answer are:
* Will participants be satisfied with the treatment, and is the treatment feasible to do in a military outpatient setting * Will the treatment help with anger and aggression issues.
Researchers will compare differences in groups that have different wait times (2-, 3-, or 4-weeks).
Participants will complete surveys before, during and after the treatment. The treatment will be 14 modules given twice a week. About 1 month after treatment ends, surveys will be taken again.
Eligibility criteria
Qualifiers
Adult active duty military service members and veterans aged 18 or older.
Endorses a history of military-related betrayal (on the Modified Moral Injury Questionnaire)
Endorses problematic anger in the past month (as evidenced by a score of 12 or above on the Dimensions of Anger Reactions; DAR-5)
Engaged in at least 1 self-reported act of aggression in the past 1 month (on the Overt Aggression Scale-Modified; OAS-M)
Disqualifiers
Participated in an anger management or trauma-focused intervention within the past 3 months as assessed by self-report.
Acute suicidality requiring immediate intervention, such as hospitalization as assessed by the Depressive Symptoms Index-Suicidality Subscale (DSI-SS) combined with follow up clinical interview for elevated scores.
Is currently homicidal with plans and intent to hurt a specific person and requiring immediate intervention as measured by self-report and follow-up with clinician if screened positive.
Moderate to severe brain injury as measured by inability to comprehend the informed consent document or baseline assessments.
Trial design
Treatments tested in this trial
- Countering Chronic Anger and Aggression Related to Trauma and Transgressions (CART)
Treatment groups
Sponsors and collaborators
The University of Texas Health Science Center at San Antonio
Lead sponsor
United States Department of Defense
Collaborator